Ollier's Disease Market: Can Surgical Innovation Address the Unmet Need in Enchondromatosis Management?
Ollier's disease surgical intervention — the enchondromatosis treatment dominated by curettage, bone grafting, and limb reconstruction procedures for the approximately 1 in 100,000 affected individuals — represents the primary commercial activity in a market constrained by the absence of pharmacological therapies, with the Ollier's Disease Market reflecting surgical and orthopedic...
0 Commentaires 0 Parts 8 Vue